ATE235558T1 - Transformation von tierischen somatischen zellen mittels partikeln - Google Patents

Transformation von tierischen somatischen zellen mittels partikeln

Info

Publication number
ATE235558T1
ATE235558T1 AT90910074T AT90910074T ATE235558T1 AT E235558 T1 ATE235558 T1 AT E235558T1 AT 90910074 T AT90910074 T AT 90910074T AT 90910074 T AT90910074 T AT 90910074T AT E235558 T1 ATE235558 T1 AT E235558T1
Authority
AT
Austria
Prior art keywords
animals
transformation
somatic cells
particles
spark discharge
Prior art date
Application number
AT90910074T
Other languages
English (en)
Inventor
Winston J Brill
Dennis E Mccabe
Ning-Sun Yang
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27005554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE235558(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of ATE235558T1 publication Critical patent/ATE235558T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Electromagnetism (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
AT90910074T 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln ATE235558T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37186989A 1989-06-26 1989-06-26
US49493390A 1990-03-14 1990-03-14
PCT/US1990/003522 WO1991000359A1 (en) 1989-06-26 1990-06-21 Particle-mediated transformation of animal somatic cells

Publications (1)

Publication Number Publication Date
ATE235558T1 true ATE235558T1 (de) 2003-04-15

Family

ID=27005554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90910074T ATE235558T1 (de) 1989-06-26 1990-06-21 Transformation von tierischen somatischen zellen mittels partikeln

Country Status (10)

Country Link
US (2) US20020081739A1 (de)
EP (1) EP0431135B1 (de)
JP (2) JP3573454B2 (de)
AT (1) ATE235558T1 (de)
AU (2) AU5856790A (de)
CA (1) CA2019676C (de)
DE (1) DE69034053T2 (de)
DK (1) DK0431135T3 (de)
ES (1) ES2194834T3 (de)
WO (1) WO1991000359A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0500799B1 (de) 1989-11-16 1998-01-14 Duke University Transformation von tierischen Hautzellen mit hilfe von Partikeln
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
DE69227872T3 (de) * 1991-03-06 2003-12-04 Monsanto Technology Llc, St. Louis Partikel-auslösende transformation von baumwolle
WO1993008270A1 (en) * 1991-10-15 1993-04-29 Agracetus, Inc. Particle-mediated transformation of mammalian unattached cells
JPH06503479A (ja) * 1991-10-16 1994-04-21 オラージェン，　インコーポレイテッド 動物体細胞の粒子−媒介トランスフォーメーション
US5260191A (en) * 1992-01-30 1993-11-09 Agracetus, Inc. Method for diagnosing tumors
WO1993017697A1 (en) * 1992-03-04 1993-09-16 Wolff Jon A Method of delivering therapeutic substances to the brain
ATE295895T1 (de) * 1992-03-11 2005-06-15 Powderject Vaccines Inc Genetischer impfstoff gegen den immunschwäche virus
AU2146092A (en) * 1992-05-28 1993-12-30 Scientific Dimensions Usa, Inc. Transgenic animal production with biolistically transformed spermatozoa
WO1995001448A1 (en) * 1993-06-30 1995-01-12 Dcv Biologics L.P. A method for introducing a biological substance into a target
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US6995008B1 (en) 1994-03-07 2006-02-07 Merck & Co., Inc. Coordinate in vivo gene expression
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
BE1010344A3 (fr) * 1996-06-12 1998-06-02 Solvay Vaccin plasmidique contre le virus pseudorabique.
EP0817799A1 (de) * 1995-12-21 1998-01-14 SOLVAY (Société Anonyme) Plasmidimpfstoff gegen pseudorabiesvirus
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
US7851212B2 (en) 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
GB0201736D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd DNA dosage forms
ATE357219T1 (de) * 2002-01-25 2007-04-15 Glaxo Group Ltd Darreichungsformen für dns
EP1356820A1 (de) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
EP2411519B1 (de) 2009-03-27 2015-07-22 Institut National de la Santé et de la Recherche Médicale Kanamycin-antisense-nucleinsäure zur behandlung von krebs
CA2798837A1 (en) 2010-06-07 2011-12-15 Pfizer Inc. Her-2 peptides and vaccines
US20220135937A1 (en) * 2018-12-20 2022-05-05 National University Corporation Toyohashi University Of Technology Electroporation device and method for producing cells with introduced foreign substance
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
US11319613B2 (en) 2020-08-18 2022-05-03 Enviro Metals, LLC Metal refinement
WO2024200831A1 (en) 2023-03-30 2024-10-03 Vivadju Pvax14 nucleic acid in combination with all-trans retinoic acid (atra) and a checkpoint inhibitor for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
US5015580A (en) * 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
US5405779A (en) * 1993-04-09 1995-04-11 Agracetus, Inc. Apparatus for genetic transformation
US5506125A (en) * 1993-12-22 1996-04-09 Agracetus, Inc. Gene delivery instrument with replaceable cartridges

Also Published As

Publication number Publication date
US20050216959A1 (en) 2005-09-29
DK0431135T3 (da) 2003-07-21
CA2019676A1 (en) 1990-12-26
EP0431135B1 (de) 2003-03-26
CA2019676C (en) 2005-08-09
AU5856790A (en) 1991-01-17
US20020081739A1 (en) 2002-06-27
AU5787394A (en) 1994-05-19
JPH04500314A (ja) 1992-01-23
DE69034053T2 (de) 2003-12-04
WO1991000359A1 (en) 1991-01-10
JP3573454B2 (ja) 2004-10-06
DE69034053D1 (de) 2003-04-30
AU679477B2 (en) 1997-07-03
ES2194834T3 (es) 2003-12-01
EP0431135A1 (de) 1991-06-12
JP2001213807A (ja) 2001-08-07

Similar Documents

Publication Publication Date Title
DE69034053D1 (de) Transformation von tierischen somatischen zellen mittels partikeln
Preetam et al. Electrical stimulation: a novel therapeutic strategy to heal biological wounds
US5318514A (en) Applicator for the electroporation of drugs and genes into surface cells
ES2116986T3 (es) Composiciones de metal-peptidos y metodos cosmeticos para estimular el crecimiento del cabello.
DK0400958T3 (da) Levende vacciner
ATE294613T1 (de) Vorrichtung zur behandlung von tumor-erkrankungen ( krebsleiden )
HUP9702388A2 (hu) Növekedésihormon-kibocsátást serkentő vegyületek és ezeket tartalmazó gyógyszerkészítmények
DE3876756D1 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
BR0207399A (pt) Método de terapia com células para o tratamento de tumores
NO932101L (no) Polypeptidmateriale som er anvendelig ved terapeutisk behandling av mennesker
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
ATE320270T1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
Connolly et al. Optimization of a plasma facilitated DNA delivery method
Bravo et al. Microcurrent stimulates cell proliferation and modulates cytokine release in fibroblast cells
Fields et al. Somatovisceral pathway: rapidly conducting fibers in the spinal cord
Bouzarjomehri et al. Effects of low-frequency pulsed electromagnetic fields on wound healing in rat skin
Leong et al. Muscle protection following motor nerve repair in combination with leukemia inhibitory factor
HARTLEY et al. Experimental osteogenesis in rabbit muscle
SU1713600A1 (ru) Способ лечени диспепсии жвачных животных
Raheel et al. Immune potentiating effect of bee venom on humoral parameters of innate immunity in broiler chickens.
CN111172151A (zh) 一种电信号通过调节皮肤DCs/LCs提呈至T细胞而调控机体免疫反应的方法及其用途
RU94039629A (ru) Стимулятор роста костномозговых клеток человека
SU1463301A1 (ru) Устройство дл сбора да от скорпиона
SE8002898L (sv) Biologiskt aktiv substans och forfarande for framstellning derav
Tas et al. Investigación de los Efectos Neurorregenerativos de Biorresonancia y Magnetoterapia en Ratas Inducidas por Daño del Nervio Ciático

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0431135

Country of ref document: EP

RZN Patent revoked